BTR Capital Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $16.2M | Sell |
186,542
-2,610
| -1% | -$233K | 2.53% | 12 |
|
|
2022
Q2 | $17.4M | Sell |
189,152
-1,040
| -0.5% | -$92.2K | 2.49% | 14 |
|
|
2022
Q1 | $15.6M | Buy |
190,192
+78
| +0% | +$6.15K | 1.92% | 19 |
|
|
2021
Q4 | $14.6M | Sell |
190,114
-19
| -0% | -$1.51K | 1.64% | 24 |
|
|
2021
Q3 | $14.3M | Buy |
190,133
+2,277
| +1% | +$173K | 1.77% | 25 |
|
|
2021
Q2 | $14.6M | Buy |
187,856
+2,068
| +1% | +$154K | 1.82% | 21 |
|
|
2021
Q1 | $13.7M | Buy |
185,788
+11,230
| +6% | +$828K | 1.99% | 18 |
|
|
2020
Q4 | $13.6M | Buy |
174,558
+3,509
| +2% | +$268K | 2.13% | 16 |
|
|
2020
Q3 | $13.5M | Sell |
171,049
-2,489
| -1% | -$195K | 2.4% | 15 |
|
|
2020
Q2 | $12.8M | Buy |
173,538
+9,524
| +6% | +$717K | 2.4% | 14 |
|
|
2020
Q1 | $12M | Buy |
164,014
+19,831
| +14% | +$1.56M | 2.66% | 11 |
|
|
2019
Q4 | $12.5M | Sell |
144,183
-917
| -0.6% | -$75.3K | 2.16% | 15 |
|
|
2019
Q3 | $11.7M | Sell |
145,100
-292
| -0.2% | -$23.4K | 2.19% | 15 |
|
|
2019
Q2 | $11.6M | Buy |
145,392
+4,339
| +3% | +$332K | 2.17% | 15 |
|
|
2019
Q1 | $11.2M | Sell |
141,053
-16,145
| -10% | -$1.21M | 2.15% | 14 |
|
|
2018
Q4 | $11.5M | Sell |
157,198
-5,989
| -4% | -$423K | 2.41% | 12 |
|
|
2018
Q3 | $11M | Sell |
163,187
-211
| -0.1% | -$13.4K | 1.92% | 20 |
|
|
2018
Q2 | $9.46M | Sell |
163,398
-206
| -0.1% | -$11.6K | 1.82% | 21 |
|
|
2018
Q1 | $8.5M | Buy |
163,604
+12,959
| +9% | +$700K | 1.7% | 25 |
|
|
2017
Q4 | $8.09M | Buy |
150,645
+49,642
| +49% | +$2.75M | 1.58% | 28 |
|
|
2017
Q3 | $6.17M | Sell |
101,003
-152
| -0.2% | -$9.21K | 1.26% | 38 |
|
|
2017
Q2 | $6.19M | Buy |
101,155
+545
| +0.5% | +$33.2K | 1.27% | 39 |
|
|
2017
Q1 | $6.1M | Buy |
100,610
+29,208
| +41% | +$1.77M | 1.28% | 36 |
|
|
2016
Q4 | $4.25M | Hold |
71,402
| – | – | 0.95% | 38 |
|
|
2016
Q3 | $4.25M | Sell |
71,402
-19,277
| -21% | -$1.13M | 0.95% | 38 |
|
|
2016
Q2 | $4.99M | Sell |
90,679
-3,129
| -3% | -$167K | 1.14% | 36 |
|
|
2016
Q1 | $4.74M | Sell |
93,808
-1,849
| -2% | -$90.6K | 1.1% | 38 |
|
|
2015
Q4 | $4.82M | Buy |
95,657
+2,410
| +3% | +$122K | 1.1% | 36 |
|
|
2015
Q3 | $4.39M | Buy |
93,247
+446
| +0.5% | +$23.7K | 1.05% | 39 |
|
|
2015
Q2 | $5.04M | Buy |
92,801
+4,139
| +5% | +$232K | 1.19% | 35 |
|
|
2015
Q1 | $4.86M | Sell |
88,662
-168
| -0.2% | -$9.51K | 1.18% | 34 |
|
|
2014
Q4 | $4.81M | Buy |
88,830
+6,699
| +8% | +$373K | 1.31% | 30 |
|
|
2014
Q3 | $4.65M | Sell |
82,131
-1,594
| -2% | -$89.5K | 1.28% | 33 |
|
|
2014
Q2 | $4.62M | Sell |
83,725
-4,332
| -5% | -$236K | 1.27% | 32 |
|
|
2014
Q1 | $4.77M | Sell |
88,057
-7,525
| -8% | -$390K | 1.39% | 30 |
|
|
2013
Q4 | $4.57M | Sell |
95,582
-550
| -0.6% | -$25.1K | 1.3% | 31 |
|
|
2013
Q3 | $4.37M | Sell |
96,132
-4,166
| -4% | -$190K | 1.37% | 32 |
|
|
2013
Q2 | $4.45M | Buy |
+100,298
| New | +$4.48M | 1.38% | 28 |
|
Other funds holding MRK
BTR Capital Management's MRK Position: Q3 2022 in Review
BTR Capital Management reduced its Merck (MRK) stake by 1.4% in Q3 2022, selling an estimated $233K and leaving 186,542 shares worth $16.2M. The position accounts for 2.53% of the portfolio, ranked #12.
BTR Capital Management first reported a position in MRK in Q2 2013 and has held it in 38 quarters since. The position peaked at $17.4M in Q2 2022. 2,989 funds tracked by Wall St. Rank hold MRK as of Q3 2022.
- BTR Capital Management held 186,542 shares of Merck worth $16.2M as of Q3 2022.
- BTR Capital Management sold 2,610 Merck shares in Q3 2022, an estimated $233K.
- Merck made up 2.53% of BTR Capital Management's portfolio in Q3 2022, its #12 holding.
- BTR Capital Management first reported a position in Merck in Q2 2013 and has held it in 38 quarters since.
- BTR Capital Management's Merck position peaked at $17.4M in Q2 2022.
- 2,989 funds tracked by Wall St. Rank held Merck as of Q3 2022.
Based on BTR Capital Management's 13F filing for Q3 2022, filed 12 Oct 2022.